A collection of news and information related to Vivus Inc. published by this site and its partners.
Displaying items 1-9 of 9 » View ktuu.com items only
Reports: MBA mortgage index for week ended May 4, 6:30 a.m.; Crude inventories for week ended May 4, 9:30 a.m. Local earnings: CF Industries Holdings Inc., Groupon Inc., Manitex International Inc., Middleby Corp., MYR Group Inc., Nanosphere Inc.,...
Los hombres con disfunción eréctil quizás no tengan que volver a hacer planes adelantados para tener relaciones sexuales, luego de que Vivus Inc. ganara la aprobación en Estados Unidos de su producto Avanafil, que viene a competir con Viagra, de Pfizer...
The diet drug Qnexa helps obese people with weight-related medical conditions to lose more weight than those who take a dummy pill and could allow some to scale back on medications for diabetes, high blood pressure or cholesterol, according to a new study...
The FDA has told the makers of the proposed weight-loss drug Lorcaserin that it will not at this time approve the marketing of the medication, citing concerns about its marginal effectiveness and about cancers that occurred at higher-than-usual rates...
Tribune NewspapersThere has never been a magic prescription to help millions of obese Americans lose weight. Whether one is any closer to reality is now under scrutiny. A Food and Drug Administration advisory panel will decide Wednesday whether the diet drug Meridia...
Daily PressProducts by two Hampton Roads organizations are on the cutting edge of wound care. The nonprofit LifeNet Health in Virginia Beach offers TheraSkin, a graft made of real skin that stimulates your body to heal itself. Soluble Systems of Newport News...
Los Angeles Times Staff WriterThis is not shaping up to be a good year for people seeking medical help for weight loss. A Food and Drug Administration advisory committee on Thursday voted against recommending approval of the drug lorcaserin. This is the third negative vote on...
Booster ShotsAbout this time last year, we were reporting on the failure of several investigational weight-loss medications. They included Sanofi-Aventis' rimonabant as well as two other drugs that aimed to work by blocking cannabinoid receptors in the brain. However,...
KTLA NewsLOS ANGELES -- It's a condition called 'Female Sexual Dysfunction," or 'FSD,' supposedly afflicting women who are dissatisfied with their sex lives. It's been widely reported to affect 43 percent of all women -- but it is real? Documentary filmmaker...
May 8, 2013 |Story| Chicago Tribune
Apr 30, 2012 |Story| South Florida Sun-Sentinel
Apr 11, 2011 |Story| Los Angeles Times
Oct 25, 2010 |Story| Los Angeles Times
Sep 15, 2010 |Story| Chicago Tribune
Nov 17, 2010 |Story| Daily Press
Sep 17, 2010 |Story| Los Angeles Times
Oct 28, 2009 | Los Angeles Times
May 5, 2010 |Story| KTLA-LTV
Original site for Vivus Inc. topic gallery.